Dr. Peter O’Hare, a member of the Clinical Engineering team at HeartSine Technologies, recently delivered a presentation at the 2013 Resuscitation Science Symposium (ReSS), hosted by the American Heart Association in Dallas, Texas. Dr O’Hare’s presentation was entitled “Does Real-Time Audio Feedback from an Automated External Defibrillator Enhance Cardiopulmonary Resuscitation Quality during Emergency Resuscitation?”
Dr. O’Hare said: “The ReSS is a major international forum where clinicians and researchers come together to discuss their understanding and improvement of resuscitation care.
“It also is an arena to discuss recent advances relating to the treatment of cardiopulmonary arrest and life-threatening traumatic injury.
“All HeartSine defibrillators, which are manufactured in Belfast, are complete with audio prompts (in over 29 languages) to talk the responder through the save process, step by step. However, the HeartSine samaritan PAD 500P will actually provide the responder with real time feedback on their cardiopulmonary resuscitation (CPR) efforts, instructing them to ‘push faster’, ‘push slower’, push harder’ or instructing them when they are giving ‘good compressions’ to the patient.
“We collected data from events recorded by HeartSine devices, during actual rescue attempts over a five month period, and analysed the events to see how well untrained rescuers responded to these instructions. The data we presented shows overwhelmingly that these prompts significantly improve the quality of CPR given by the lay person to the patient in an emergency situation.”
Topics covered at the Conference, which took place in the Omni Dallas Hotel’s Dallas Ballroom, include Hypothermia, Acute Cardiovascular and Cerebrovascular Care, and Out-of-Hospital Cardiac Arrest.
Declan O’Mahoney, Chief Executive of HeartSine Technologies, which distributes Automated External Defibrillators (AEDs) in more than 40 countries worldwide, said: “Clinicians and researchers travel from across the world to attend ReSS and I am delighted that Dr. O’Hare was able to represent HeartSine at such a hotly anticipated global event. HeartSine is already at the cutting edge of out of hospital defibrillation but we are always keen to engage with other experts and share our knowledge by way of advancing resuscitation and cardiac arrest treatment.”
Data from Dr. O’Hare’s study will be published in the near future.